What Final Dosage Form Means in Drug Development
Final dosage form development is frequently an underestimated risk area in drug programmes, where promising APIs fail to translate into consistent clinical performance due to formulation variability, stability limitations, or manufacturing constraints. Addressing this starts with treating the final dosage form as a controlled system from the outset. Early alignment of formulation, process parameters, and […]